Clinical Trials - Phase II
Filter News
Found 29,785 articles
-
Can-Fite BioPharma to Initiate a Phase II Study With CF102 in 130 Patients With Advanced Liver Cancer
8/28/2013
-
Acura Pharmaceuticals, Inc.'s Abuse-Deterrent Pain Drug Fails Phase 2 Study Goal; Stock Falls -19.79% at Market Close (August 27, 2013)
8/27/2013
-
OncoGenex Pharmaceuticals Inc. Announces that the Rainier Clinical Trial Evaluating Apatorsen (OGX-427) in Combination With ABRAXANE® Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer is Now Open for Enrollment
8/27/2013
-
Rigel Pharmaceuticals, Inc. Shares Fall After Asthma Drug Fails to Meet Phase 2 Goals; Stock Falls -13.50% at Market Close (August 26, 2013)
8/26/2013
-
Oncolytic Virus Specialist Virttu Biologics Confirms Treatment of First Cohort of Patients in Phase I/II SEPREHVIR® Study in Mesothelioma
8/26/2013
-
Incyte Corporation Surges on Positive Phase 2 Pancreatic Cancer Data; Stock Rockets +33.48% Wednesday, August 21, 2013 at Market Close
8/23/2013
-
FDA Grants "Breakthrough Status" to Novartis AG's Muscle Wasting Drug
8/22/2013
-
Nuvilex's Cell Encapsulation Technology Threatens Eli Lilly and Company's Gemzar
8/22/2013
-
Merrimack Pharmaceuticals Inc. Release: Study of Novel Nanoliposomal Irinotecan (MM-398) in Late Stage Pancreatic Cancer Published in British Journal of Cancer
8/22/2013
-
BioLife Solutions, Inc. HypoThermosol® Embedded in Two Intercytex Clinical Trials of Cell-Based Wound Care
8/22/2013
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Up, Then Down, on DMD Competitor's Trial Results
8/21/2013
-
AIT Ltd and Clalit Health Services Expand Strategic Alliance and Plan Phase II Clinical Trial for Respiratory Diseases
8/21/2013
-
Oramed Pharmaceuticals Inc. Initiates Patient Recruitment for a New Clinical Trial in Israel of its Oral Insulin Drug ORMD-0801 in the Treatment of Type 1 Diabetes
8/21/2013
-
Catabasis Pharmaceuticals, Inc. Initiates Phase 2 Trial of CAT-2003 in Patients With Hypertriglyceridemia and Hypercholesterolemia
8/21/2013
-
Oncopeptides AB Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
8/20/2013
-
BIND Therapeutics Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Prostate Cancer
8/19/2013
-
Selexys Pharmaceuticals Corporation Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients With Pain Crises
8/19/2013
-
Athersys, Inc. Hits Snag Recruiting Patients for Stem Cell Trial
8/16/2013
-
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
8/16/2013
-
Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
8/15/2013